Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality way.

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – especially mRNA vaccines – will become a hot topic. Is there anything to fear ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

BioNTech plans to further investigate the drug’s potential in combination with mRNA vaccines, targeted therapies and ...